Publikationen
Reviewed journal articles
Arend*† C., Grothaus* I.L., Waespy M., Dringen R. (2021). Inhibition of Mrp1-mediated transport processes in astrocytes by the HIV protease inhibitor ritonavir: new results obtained in export studies and by in silico docking analysis. Manuscript. (†corresponding author, *joint first authors)
Arend C., Ehrke E., Dringen R. (2019). Consequences of a metabolic glucose-depletion on the survival and the metabolism of cultured rat astrocytes. Neurochemical Research 44: 2288-2300.
Raabe* J., Arend* C., Steinmeier J., Dringen R. (2019). Dicoumarol inhibits multidrug resistance protein 1-mediated export processes in cultured primary rat astrocytes. Neurochemical Research 44, 333-346. (*joint first authors)
Arend C., Rother A., Stolte S., Dringen R. (2016). Consequences of a chronic exposure of cultured brain astrocytes to the anti-retroviral drug efavirenz and its primary metabolite 8-hydroxy efavirenz. Neurochemical Research 41, 3278-3288.
Ehrke* E., Arend* C., Dringen R. (2015). 3-Bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes. Journal of Neuroscience Research 93, 1138-1146. (*joint first authors)
Arend* C., Brandmann* M., Dringen R. (2013). The antiretroviral protease inhibitor ritonavir accelerates glutathione export from cultured primary astrocytes. Neurochemical Research 38, 732-741. (*joint first authors)
Abstracts
Arend C., Waespy M., Dringen R. (2021). Modulation of Mrp1-mediated transport processes in cultured rat astrocytes by the HIV protease inhibitor ritonavir: new insights from export studies and in silico docking analysis. ISN-JNC Flagship School, accepted.
Arend C., Brandmann M., Harder T., Dringen R. (2019). Screening of substances for biocompatibility based on the proliferation of C6 glioma cells. Journal of Neurochemistry 150: 246.
Arend C., Dringen R. (2017). Acute and chronic exposure to ritonavir stimulates GSH export from cultured astrocytes via the multidrug resistance protein 1. Journal of Neurochemistry 142: 63-64.
Arend C., Rother A., Stolte S., Dringen R. (2016).Consequences of a chronic exposure of cultured brain astrocytes to the antiretroviral drug efavirenz and its primary metabolite 8-hydroxy efavirenz. Abstract book, 12th International Conference on Brain Energy Metabolism, Hong Kong (May 2016).
Arend C., Ehrke E., Dringen R. (2014). Adverse effects of 3-bromopyruvate on cultured astrocytes. Abstract-Buch, 11th International Conference on Brain Energy Metabolism, Bymosehegn, Helsinge, Denmark (May 2014).